HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugenii A Rabiner Selected Research

Glycoproteins (Glycoprotein)

6/2023Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A.
1/2021The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
1/2020Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.
1/2020Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eugenii A Rabiner Research Topics

Disease

14Schizophrenia (Dementia Praecox)
02/2024 - 05/2004
8Neuroinflammatory Diseases
12/2020 - 01/2011
8Parkinson Disease (Parkinson's Disease)
01/2020 - 10/2015
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2010
5Cognitive Dysfunction
02/2024 - 08/2017
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 03/2012
4Inflammation (Inflammations)
01/2020 - 12/2016
3Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
01/2023 - 01/2020
3Multiple Sclerosis
11/2017 - 07/2014
2Mental Disorders (Mental Disorder)
09/2023 - 01/2014
2Atrophy
01/2022 - 11/2017
2Disorders of Excessive Somnolence (Hypersomnia)
01/2020 - 12/2016
2Gambling (Pathological Gambling)
01/2020 - 11/2017
2Alcoholism (Alcohol Abuse)
01/2020 - 06/2014
2Disease Progression
10/2019 - 11/2017
2Opioid-Related Disorders (Opiate Addiction)
11/2017 - 01/2016
2Huntington Disease (Huntington's Disease)
09/2016 - 10/2015
2Substance-Related Disorders (Drug Abuse)
01/2016 - 01/2014
2Psychotic Disorders (Schizoaffective Disorder)
08/2015 - 09/2002
2Major Depressive Disorder (Major Depressive Disorders)
08/2013 - 03/2012
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
09/2023
1Neuralgia (Stump Neuralgia)
01/2022
1Synucleinopathies
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
12/2020
1Proteostasis Deficiencies
01/2020
1Gliosis
10/2019
1Movement Disorders (Movement Disorder)
01/2019
1Parkinsonian Disorders (Parkinsonism)
01/2019
1Rheumatoid Arthritis
01/2018
1Neurobehavioral Manifestations
08/2017
1Dementia (Dementias)
08/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2016
1Spinal Cord Diseases
12/2016
1Encephalitis (Encephalitis, Rasmussen)
12/2016
1Crohn Disease (Crohn's Disease)
11/2016
1Dyskinesias (Dyskinesia)
10/2015
1Bipolar Disorder (Manic Depressive Psychosis)
11/2013
1Obesity
11/2011

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2013
6Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020 - 10/2015
5LigandsIBA
10/2021 - 01/2014
5Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2011
4Glycoproteins (Glycoprotein)IBA
06/2023 - 01/2020
4mu Opioid Receptors (mu Opioid Receptor)IBA
01/2023 - 01/2016
3KisspeptinsIBA
01/2023 - 01/2020
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 10/2021
3Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 02/2005
3Dopamine D3 ReceptorsIBA
12/2016 - 01/2014
3Dopamine (Intropin)FDA LinkGeneric
08/2015 - 06/2007
35-HT1A Serotonin ReceptorIBA
09/2008 - 05/2004
2Glutamic Acid (Glutamate)FDA Link
02/2024 - 01/2021
2Histamine (Histamine Dihydrochloride)FDA Link
10/2023 - 07/2010
2carfentanil (carfentanyl)IBA
01/2023 - 10/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2010
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2020 - 01/2019
2RolipramIBA
01/2020 - 08/2017
2Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 09/2002
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020 - 08/2017
2EnzymesIBA
01/2020 - 10/2015
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/2020 - 01/2020
2SynucleinsIBA
10/2019 - 01/2019
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
10/2019 - 01/2019
2Levodopa (L Dopa)FDA LinkGeneric
08/2017 - 10/2015
2(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA
01/2017 - 12/2016
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
09/2008 - 02/2005
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
10/2023
1Hallucinogens (Psychedelics)IBA
09/2023
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2022
1Amyloid beta-PeptidesIBA
01/2022
1Sigma-1 ReceptorIBA
01/2022
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
10/2021
1N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA
10/2021
1N-acetylaspartate (N-acetyl aspartate)IBA
01/2021
1Purinergic P2X7 ReceptorsIBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2020
1ImidazolinesIBA
10/2019
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
01/2019
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2019
13- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1GABA-A Receptors (GABA(A) Receptor)IBA
11/2017
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2017
1GSK2647544IBA
01/2017
1naxagolideIBA
12/2016
1Dopamine Receptors (Dopamine Receptor)IBA
12/2016
1FluorineIBA
11/2016
1Huntingtin ProteinIBA
09/2016
1Opioid Receptors (Opioid Receptor)IBA
01/2016
1IMA107IBA
01/2016
1Cocaine (Cocaine HCl)IBA
01/2016
1GSK215083IBA
12/2015
13- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA
12/2015
1(18F)FEMPAIBA
03/2015
11- (3,4- dichlorophenyl)- 6- (methoxymethyl)- 4- azabicyclo(4.1.0)heptaneIBA
08/2013
1HeptanesIBA
08/2013
1Harmine (Telepathine)IBA
03/2012
1Monoamine Oxidase (MAO)IBA
03/2012
1Glycine Plasma Membrane Transport ProteinsIBA
12/2011

Therapy/Procedure

6Therapeutics
09/2023 - 01/2010
3Drug Therapy (Chemotherapy)
01/2022 - 01/2014